The initiation and progression of pancreatic ductal adenocarcinoma through a p53 lens

被引：0
|
作者：
Hanson, Kathryn J.
Minor, Allegra C.
Flowers, Brittany M.
Kaiser, Alyssa M.
Hughes, Nicholas
Vogel, Hannes
Cong, Le
Attardi, Laura D.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 02期
关键词：
D O I：
10.1158/1538-7445.PANCA2023-C056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C056
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Is loss of p53 a driver of ductal carcinoma in situ progression?
    Morrissey, Rhiannon L.
    Thompson, Alastair M.
    Lozano, Guillermina
    BRITISH JOURNAL OF CANCER, 2022, 127 (10) : 1744 - 1754
  • [22] Is loss of p53 a driver of ductal carcinoma in situ progression?
    Rhiannon L. Morrissey
    Alastair M. Thompson
    Guillermina Lozano
    British Journal of Cancer, 2022, 127 : 1744 - 1754
  • [23] Apoptosis and Expression of the Bcl-2 Family of Proteins and P53 in Human Pancreatic Ductal Adenocarcinoma
    Chen, Dong
    Zheng, Xuefeng
    Kang, Dalu
    Yan, Bomin
    Liu, Xiaoyi
    Gao, Yuan
    Zhang, Kejun
    MEDICAL PRINCIPLES AND PRACTICE, 2011, 21 (01) : 68 - 73
  • [24] EXPRESSION OF P53 NUCLEOPHOSPHOPROTEIN IN IN-SITU PANCREATIC DUCTAL ADENOCARCINOMA - AN IMMUNOHISTOCHEMICAL ANALYSIS OF 100 CASES
    HAMEED, M
    MARRERO, AM
    CONLON, KC
    BRENNAN, MF
    KLIMSTRA, DS
    LABORATORY INVESTIGATION, 1994, 70 (01) : A132 - A132
  • [25] MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
    Dhayat, Sameer A.
    Mardin, Wolf Arif
    Seggewiss, Jochen
    Stroese, Anda Jana
    Matuszcak, Christiane
    Hummel, Richard
    Senninger, Norbert
    Mees, Soeren Torge
    Haier, Joerg
    PLOS ONE, 2015, 10 (11):
  • [26] Molecular analysis of the p53 gene in pancreatic adenocarcinoma
    Li, YW
    Bhuiyan, M
    Vaitkevicius, VK
    Sarkar, FH
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1998, 7 (01) : 4 - 9
  • [27] ABERRATION OF THE P53 GENE IN HUMAN PANCREATIC DUCTAL ADENOCARCINOMAS
    KONDOH, S
    NAKAMURA, M
    HARIMA, K
    NOGUCHI, T
    AKIYAMA, T
    OKITA, K
    GASTROENTEROLOGIA JAPONICA, 1993, 28 (01): : 134 - 134
  • [28] Setdb1 deletion protects against formation of pancreatic ductal adenocarcinoma through inducing apoptosis and upregulating p53 expression
    Ogawa, Satoshi
    Fukuda, Akihisa
    Tsuda, Motoyuki
    Masuda, Tomonori
    Sono, Makoto
    Fukunaga, Yuichi
    Yoshikawa, Takaaki
    Araki, Osamu
    Nagao, Munemasa
    Goto, Norihiro
    Hiramatsu, Yukiko
    Maruno, Takahisa
    Shinkai, Yoichi
    Seno, Hiroshi
    CANCER RESEARCH, 2019, 79 (13)
  • [29] A pilot clinical trial of p53/p16-independent epigenetic therapy for pancreatic ductal adenocarcinoma (PDA)
    Sohal, Davendra
    Krishnamurthi, Smitha S.
    Tohme, Rita
    Shepard, Dale Randall
    Khorana, Alok A.
    Saunthararajah, Yogen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [30] The Predictive Role of p16 Deletion, p53 Deletion, and Polysomy 9 and 17 in Pancreatic Ductal Adenocarcinoma
    Luo, Yanli
    Tian, Ling
    Feng, Ye
    Yi, Miaoying
    Chen, Xiafang
    Huang, Qian
    PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (01) : 35 - 40
12345